BNGOW (Bionano Genomics) OCF Margin %: -85.48% (As of Mar. 2026)


BNGOW Bionano Genomics Inc BNGOW
64 GF Score
Price $0.00
! 3 Warning Signs
View Full Analysis

What is Bionano Genomics OCF Margin %?

Bionano Genomics BNGOW 64 OCF Margin % is -85.48% as of Mar. 2026. GuruFocus rates BNGOW with a GF Score™ of 64/100. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Bionano Genomics ranks worse than 81.72% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Bionano Genomics's Cash Flow from Operations for the three months ended in Mar. 2026 was $-5.72 Mil. Bionano Genomics's Revenue for the three months ended in Mar. 2026 was $6.69 Mil. Therefore, Bionano Genomics's OCF Margin % for the quarter that ended in Mar. 2026 was -85.48%.

As of today, Bionano Genomics's current OCF Yield % is -147.51%.

The historical rank and industry rank for Bionano Genomics's OCF Margin % or its related term are showing as below:


During the past 10 years, the highest OCF Margin % of Bionano Genomics was -57.33%. The lowest was -450.59%. And the median was -318.70%.

BNGOW's OCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.86
* Ranked among companies with meaningful OCF Margin % only.

Bionano Genomics OCF Margin % Related Terms

Bionano Genomics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Bionano Genomics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionano Genomics OCF Margin % Chart

Bionano Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -400.02 -448.95 -346.61 -223.95 -57.33

Bionano Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -42.81 -51.79 -80.34 -52.51 -85.48
BNGOW
64GF Score
Bionano Genomics Inc BNGOW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionano Genomics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Bionano Genomics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-16.345/28.508
=-57.33 %

Bionano Genomics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-5.716/6.687
=-85.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -85.48% mean?
Bionano Genomics (BNGOW) has a OCF Margin % of -85.48% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bionano Genomics and its competitors. According to the industry distribution chart, Bionano Genomics ranks #666 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 81.7%.
Is Bionano Genomics' OCF Margin % too high?
Bionano Genomics' current OCF Margin % is -85.48%. Based on the distribution chart, Bionano Genomics ranks #666 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bionano Genomics has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Bionano Genomics' OCF Margin % compare to UEEC and ZJYL?
According to the Medical Devices & Instruments industry distribution chart, Bionano Genomics ranks #666 out of 815 companies for OCF Margin %. This places Bionano Genomics in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bionano Genomics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionano Genomics's current OCF Margin % is -85.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionano Genomics stock overvalued right now?
Bionano Genomics (BNGOW) has a current OCF Margin % of -85.48%. The current OCF Margin % is -85.48%. Bionano Genomics' overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bionano Genomics (BNGOW), the current OCF Margin % is -85.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionano Genomics Business Description

Other Exchanges BNGO:USABNGO:Mexico
Address 9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
64GF Score

Get the complete analysis for BNGOW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price